Perfusion Safety avoids unnecessary incidents that result in adverse patient outcomes, categorized into four groups:
- Malfunctioning or defective equipment and supplies
- Communication failure between healthcare professionals
- Human error or incorrect execution of procedures
- Failure to anticipate adverse events
Student Essay Contest
In 2021, the Safety Committee created the student essay contest which awards $1,000 in prize money to the top two writers of a safety essay about patient safety and their passion for patient safety and perfusion.
Previous Winners
2021 - Jeremy Bolick (Medical University of South Carolina) and Sophia Kero (University of Nebraska Medical Center)
2022 - Jennifer Gavin-Veyna (University of Nebraska Medical Center) and Zach Gorman (University of Iowa, Carver College of Medicine)
Safety Resources
With patients’ lives in the balance, Perfusionists must prioritize safety while implementing best practices to mitigate risks and improve safety procedures. Utilize the following resources in your practice:
Failure Mode Effects Analysis (FMEA) Articles
ECMO FMEAs
CPB FMEAs
Patient Handoff Tool
The Safety Committee has developed a communication tool to standardize safe handoffs between perfusionists, called I PASS THE CLAMP OFF. The I PASS THE CLAMP OFF video describes the tool's use in everyday practice. A PDF copy is also available.
If you have a suggestion for a failure mode that you would like to see formalized in the FMEA or have questions about the FMEA or Perfusion Safety Program, contact amsect@amsect.org.
Alerts & Notifications
September 16, 2024: Orrum PSO Alert – Cracks in Crescent Jugular Dual Lumen Catheter
Background & Summary: The Crescent Jugular Dual Lumen Catheter is a “Single use dual lumen catheter, which provides both venous drainage and reinfusion of blood via the jugular vein, that is indicated for use in adult and pediatric patients with acute respiratory failure requiring Veno-Venous Extracorporeal Membrane Oxygenation where other available treatment options have failed and continued clinical deterioration is expected or the risk of death is imminent (1).” The device is FDA approved for up to 30 days of use (2). Read the full alert.
January 21, 2021: Medical Device Notice: Updated notice for Heartware HVAD systems ref #1103
In December 2020, Medtronic International Ltd issued a notice regarding Medtronic Heartware TM Ventricular Assist Device (HVAD). Medtronic has identified an issue with implanted HVADSs where the pump may experience a delay to restart or failure to restart. Pumps at a greater risk of failure are due to an internal component specific to (3) lot numbers. The issue only occurs in pumps that are stopped after the initial startup phase. Please refer to the following link for Medtronic's notice and patient management recommendations. Be advised: This issue does not impact the performance of a pump while it is running. Read the full alert.
October 15, 2020: Safety Notice - FDA Alert
On September 30th, 2020, the U.S. Food and Drug Administration posted a letter to health care providers regarding reports of nontuberculous mycobacteria (NTM) infections in patients who had undergone cardiothoracic surgery involving the use of CardioQuip Modular Cooler-Heaters.
While the root cause of infection in these cases is unknown and continues to be evaluated, the FDA provides general recommendations to reduce the risk of infection during cardiac surgery when using any heater-cooler device. We will update the community if more information becomes available. Read the full alert.
https://www.amsect.org/about/committees/safety-committeeSafety Committee
Visit the Safety Committee page.